Cabozantinib 20mg tablets
NHS hospitals in England used £36,207,399 of indicative cost of Cabozantinib 20mg tablets in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 32.6% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Cabozantinib 20mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Cabozantinib 20mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| East And North Hertfordshire Nhs Trust | £2,390,295 |
| Western Sussex Hospitals Nhs Found Trust | £1,769,878 |
| The Clatterbridge Cancer Centre Nhs Ft | £1,702,847 |
| Leeds Teaching Hpls Nhs Trust | £1,622,102 |
| Sheffield Teaching Hospitals Nhs Trust | £1,209,805 |
| The Christie Nhs Foundation Trust | £1,194,033 |
| Univ Hpls Bristol Nhs Foundation Trust | £1,182,547 |
| University Hospital Southampton Nhs Ft | £1,090,316 |
| Portsmouth Hospitals Nhs Trust | £1,038,543 |
| The Royal Marsden Nhs Foundation Trust | £1,035,965 |
The primary-care picture
Cabozantinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Cabozantinib medicine page.